Vertex Pharmaceuticals Inc (VRTX :)
| Extended Hours | --- |
---
|
--- | --- |
|
--- |
---
|
--- | --- |
VRTX FEATURED NEWS & ANALYSIS
LATEST ABOUT THIS TOPIC ON CNBC.COM
-
Many in U.S. don't get proper testing for hepatitis C- CDC 07 May 2013 - AFX
-
RESEARCH ALERT-Vertex Pharmaceuticals: UBS raises target price 01 May 2013 - AFX
-
US Stocks Seen Down; Pfizer Earnings Awaited 30 Apr 2013 - CNBC.com
-
Top Undervalued Pharma Stock: Analyst 29 Apr 2013 - CNBC.com
-
-
-
MORE FROM CNBC
-
US Stocks Seen Down; Pfizer Earnings Awaited 30 Apr 2013 - CNBC.com
-
Top Undervalued Pharma Stock: Analyst 29 Apr 2013 - CNBC.com
-
-
-
MORE FROM OUR PARTNERS
-
1 Tech, 1 Biotech And 1 Business Services Company With Recent Intensiv... 5 hrs ago - Seeking Alpha
-
This Stock Deserved Its Sudden Upswing 13 May 2013 - Seeking Alpha
-
Vertex Debt Conversion Is Not Bad For Shareholders 09 May 2013 - Seeking Alpha
-
Biotech Watchlist 2013 Update: Exciting Ideas Have Explosive Potential 03 May 2013 - Seeking Alpha
-
Vertex Pharmaceuticals Beats Analyst Expectations, Yet Insiders Contin... 03 May 2013 - Seeking Alpha
-
Why BioMarin, Catalyst Pharmaceutical Partners And Vertex Are Expected... 01 May 2013 - Seeking Alpha
-
NewLink Genetics: Looking To Join The Industry's Largest Movers 29 Apr 2013 - Seeking Alpha
-
Cramer's Lightning Round - EMC Is Controversial (4/23/13) 24 Apr 2013 - Seeking Alpha
-
Vertex Spikes On Phase II Data, Then The CFO Sell His Shares 24 Apr 2013 - Seeking Alpha
-
Catalyst Deserves The Attention 23 Apr 2013 - Seeking Alpha
LATEST TRANSCRIPTS
-
Vertex Pharmaceuticals Incorporated Management Discusses Q1 2013 Resul... 30 Apr 2013 - Seeking Alpha
PRESS RELEASES
-
Syros Pharmaceuticals Appoints Eric R. Olson, Ph.D. as Chief Scientifi... 22 May 2013 - Business Wire
-
Medivir: Primary efficacy and safety findings from phase III study of ... 21 May 2013 - Business Wire
-
Primary Efficacy and Safety Findings from Phase 3 Study of Janssen's S... 21 May 2013 - PR Newswire
-
Tens of Thousands to Walk for a Cure for Cystic Fibrosis 17 May 2013 - PR Newswire
-
Vertex Calls for Redemption of $400 Million in Convertible Senior Subo... 17 May 2013 - Business Wire
-
Vertex Pharmaceuticals Announces Webcasts of its Presentations at Two ... 09 May 2013 - Business Wire
-
Lux Capital Adds Bilal Zuberi as Partner 09 May 2013 - Business Wire
-
Vertex Reports First Quarter 2013 Financial Results and Reviews Recent... 30 Apr 2013 - Business Wire
-
Vertex Announces New Data that Showed High Viral Cure Rates with a Tot... 24 Apr 2013 - Business Wire
-
Netflix Indicating Big Jump Pre-Market on Earnings Surprise - Top Earn... 23 Apr 2013 - PR Newswire
